Loading…
Loading…
REC (Emles Real Estate Credit ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how REC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for REC and 80,000+ other tickers.
The Emles Real Estate Credit ETF (REC) seeks to replicate the performance of a market-value-weighted index. This index is designed to track corporate bonds that have been issued in the United States by U.S.-based companies (including their subsidiaries) primarily engaged in the real estate industry. The fund typically commits at least 90% of its net assets (along with any borrowed capital used for investment) to the securities comprising this index. It may also invest up to 10% of its assets in derivatives such as futures, options, and swap contracts, or hold cash and cash equivalents. This fund is categorized as non-diversified.
CALGARY, Alberta, June 17, 2026 (GLOBE NEWSWIRE) -- Record Resources Inc. (TSXV: REC) reports that it has sold the non-hydrocarbon and non-hydrogen rights on an optioned property at Lake Temiskaming, Ontario, reflecting the Company's continued prioritization of its Gabonese oil and gas assets, focused on the Ngulu block, which covers 1,214 Km2 (equivalent to 54 Gulf of Mexico blocks) and is strategically located on trend to several sizable producing oil fields and includes the Loba oil field discovery and over 28 seismically identified high impact prospects in the Pre-salt Gamba / Dentale and Post-salt plays. RJK Explorations (RJK), Kirkland Lake, Ontario, has acquired from Record Resources the rights to diamonds, precious and base metals found on the company's Lorrain-Bucke property located at Lake Timiskaming, Ontario.
Recursion Pharmaceuticals, Inc. is advancing REC-1245, an RBM39 degrader, in the DHALIA trial in solid tumors, with Q1'26 earnings noting no dose-limiting toxicities so far. Initial DHALIA trial data are based on a small cohort of 16 patients, with the drug only now reaching relevant dose levels for anti-tumor activity, limiting conclusions. A H2 '26 update from DHALIA could confirm anti-tumor activity of REC-1245, but might not have enough additional data to go beyond that.
Britain's jobs market lost momentum in April after recruiters turned more cautious about hiring as the Iran war heightened cost pressures, an industry survey showed on Monday.
Earlier this year, Recursion Pharmaceuticals Inc (NASDAQ:RXRX) initiated discussions with the FDA for the design of a registrational study for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), which represents a new way of treating this rare genetic condition without immediate surgery.
Calgary, Alberta--(Newsfile Corp. - March 18, 2026) - Record Resources (TSXV: REC), which owns three strategically located natural hydrogen properties in Ontario, plans to further assess the company's options to non-dilutively unlock value for its shareholders in order to capitalize on the AI-driven demand for natural hydrogen as a key power source for the industry. The driving factor for Record's natural hydrogen proprieties is the emerging, critical, high-efficiency requirement to supply 24/7 baseload power for the surging energy demands of AI (Artificial Intelligence) data centers, as power consumption is projected to more than double by 2030 to roughly 945 terawatt-hours (TWh).